Clinical Trial Update: Autologous Hematopoietic Stem Cell Transplantation for Refractory Multiple Sclerosis [NA]

View source ↗

Summary

This clinical trial update describes a planned autologous hematopoietic stem cell transplantation study for refractory multiple sclerosis that is not yet recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: Tianjin Medical University General Hospital | Conditions: Multiple Sclerosis | NA | Status: NOT_YET_RECRUITING